BIMI International Medical Inc.
BIMI · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $1,010 | $643 | $211 | $328 |
| - Cash | $994 | $1,932 | $1,730 | $2,337 |
| + Debt | $4,470 | $4,428 | $5,179 | $5,455 |
| Enterprise Value | $4,485 | $3,140 | $3,660 | $3,447 |
| Revenue | $2,523 | $5,558 | $3,198 | -$5,432 |
| % Growth | -54.6% | 73.8% | 158.9% | – |
| Gross Profit | $115 | $2,884 | $1,690 | -$7,750 |
| % Margin | 4.6% | 51.9% | 52.8% | 142.7% |
| EBITDA | -$3,098 | $1,284 | -$772 | -$7,879 |
| % Margin | -122.8% | 23.1% | -24.1% | 145% |
| Net Income | -$3,129 | $1,054 | -$884 | -$11,796 |
| % Margin | -124% | 19% | -27.6% | 217.2% |
| EPS Diluted | -0.49 | 0.23 | -0.23 | -4.14 |
| % Growth | -313% | 200% | 94.4% | – |
| Operating Cash Flow | -$1,484 | -$570 | $2,818 | -$2,925 |
| Capital Expenditures | -$604 | $0 | $0 | $0 |
| Free Cash Flow | -$2,088 | -$570 | $2,818 | -$2,925 |